master & commander

VOA PERSIAN NEWS

2007-11-05T17:22:00.001+03:30

VOA News - وب سايت فارسی صدای آمريکا VOA Persian homepage

https://nimtakht.com/nph-proxy.cgi/010110A/53616c7465645f5f61dd68e59235a8e80e1ccd8b1e22414fb3cffbae651ef18b0e2bfaff3b69d2dbbdbefcf48f136602 https://nimtakht.com/nph-proxy.cgi/010110A/53616c7465645f5f61dd68e59235a8e80e1ccd8b1e22414fb3cffbae651ef18b0e2bfaff3b69d2dbbdbefcf48f136602

2007-09-16T01:13:00.001+03:30

گفتمش: دل ميخري؟! پرسيد چند؟! گفتمش: دل مال تو، تنها بخند. خنده کرد و دل ز دستانم ربود تا به خود باز آمدم او رفته بود دل ز دستش روي خاک افتاده بود جاي

پايش روي دل جا
مانده بود

Yoono

2007-08-25T06:45:00.001+03:30

Google Notebook

Buprenorphine

2007-08-25T05:45:00.000+03:30

Buprenorphine, is an opioid drug with partial agonist and antagonist actions. Buprenorphine hydrochloride was first marketed in the 1980s by Reckitt & Colman (now Reckitt Benckiser) as an analgesic, available generally as Buprenex in a 0.3 mg/ml injectable formulation in the United States. In October 2002, the FDA additionally approved Suboxone and Subutex, buprenorphine's high-dose sublingual pill preparations for opioid addiction, and as such the drug is now also used for this purpose. It has been a Schedule III drug under the Convention on Psychotropic Substances^[1] since it was rescheduled from Schedule V (the schedule with the lowest restrictions and penalties) just before FDA approval of Suboxone and Subutex. In the recent years, buprenorphine has been introduced in most European countries as transdermal formulation ("patch") for the treatment of chronic pain.

Commercial preparations

British firm Reckitt & Colman (now Reckitt Benckiser) first marketed buprenorphine under the trade names Temgesic (sublingual/parenteral preparations, no active additives) and Buprenex (parenteral, no active additives). Two more recent formulations from Reckitt Benckiser have been approved for opioid addiction treatment in the U.S.: Subutex (flavorless sublingual, no active additives; in 2 mg and 8 mg dosages) and Suboxone (orange-tang flavored sublingual, one part naloxone for every four parts buprenorphine; hexagon shaped tablet in 2 mg and 8 mg dosages). Suboxone contains small doses of opiates aswell as the opioid antagonist naloxone to deter illicit intravenous preparation of the tablet. This is intended to attenuate the effects of buprenorphine on opioid-naive users should this formulation be injected - however no human studies have been done demonstrating the efficacy of this approach with buprenorphine and a growing number of street reports indicate that the naloxone is ineffective.

A solution for injection (usually by the intramuscular route) is marketed for the UK veterinary market by Alstoe Animal Health as Vetergesic, licenced for analgesia and sedation in dogs.

Since 2001 buprenorphine is also available transdermally in 35, 52.5 and 70 mcg/hour transdermal patch, that delivers the dose over 96 hours. This application form is marketed as Transtec in most European countries by Gruenenthal ^[2] (Napp Pharmaceuticals.in the UK ^[3] Norpharma in Denmark) for the treatment of moderate to severe cancer pain and severe non-cancer pain not responding to non-opioids. Moreover, a new 5, 10 and 20 mcg/hour patch is marketed as Butrans or Norspan, a once weekly patch for severe chronic pain not responding to non-opioids, marketed by Napp Pharmaceuticals Ltd., and Mundipharma and Gruenenthal respectively.

2007-08-25T05:43:00.000+03:30

Zyban

2007-08-22T04:01:00.001+03:30

bupropion: Definition and Much More from Answers.com

Dosing: Bupropion usually is given in two or three daily doses. When used for smoking cessation, bupropion usually is started as 150 mg once daily for three days, and then the dose is increased if the patient tolerates the starting dose. Smoking is discontinued two weeks after starting bupropion therapy. Wellbutrin SR is given as two daily doses. Wellbutrin XL is given as one dose daily.

Drug Interactions: Although no systematic studies have been done to assess the potential of bupropion to interact with other drugs, bupropion should be used cautiously in patients receiving drugs that reduce the threshold for seizures. Such drugs include prochlorperazine (Compazine), chlorpromazine (Thorazine), and other antipsychotic medications of the phenothiazine class. Additionally, persons who are withdrawing from benzodiazepines (e.g. diazepam, Valium; alprazolam, Xanax) are at increased risk for seizures.

فوائد مصرف متادون

2007-08-22T02:45:00.001+03:30

دارو

1 - متادون بخوبي علايم محروميت و وسوسه مصرف مواد و دارو راکاهش داده باعث جلوگيري از لغزش وعود مي شود

2 - متادون باعث ثبات زندگي بيمارشده و باعث بالارفتن خود کارآمدي اومي شود .

3 - بعلت طولاني الاثر بودن ، علايم محروميت آن خفيف ترا اما طولاني ترايجاد مي شود .

4 - خوراکي بودن متادون باعث میشود رفتارهاي پرخطر مثل نزريق مشترک کاهش يافته وعوارض حاصله مانند ايدز، هپاتيت و ... کاهش مي يابد.

5 - ارتکاب جرايم بامصرف متادون کاهش مي يابد .

6 - مصرف متادون مرگ ومير ناشي از مصرف مواد راکاهش مي دهد .

شرايط پذيرش بيماران
اين نوع درمان براي بيماران باشرايط ذيل مناسب مي باشد :

1- مصرف تزريقي

2- مصرف هروئين

3- مصرف کريستال وکراک

4- مصرف ترياک يا شیره درصورت وجود سابقه حداقل سه بار عود پس ازدرمان يا حداقل 10 سال سابقه مصرف مواد

5- بيماران مبتلا به ایدز

2007-08-07T04:41:00.001+03:30

N.A_______WAY

2007-08-07T04:40:00.001+03:30

NA_way

فرمانده و استاد

2007-07-31T06:17:00.000+03:30

اینجا ایران است ،سرزمین شیران بود،ببخشید است ،ليكن شیرانش گویی کهنسال شده اند و هنوز بچه شیرها هم بزرگ

نشده اند یا اگر هم شده اند کار آموخته نشده اند انشا الله خواهند شد.انشاالله